Industry Detail

Comprehensive Analysis on Pathological Labs in United States: A Insights Report

Introduction: Rising infections after COVID-19 pandemic has also increased the demand for blood sample collection. In United States innovations in diagnosis leading clinical industry. Being a developed country there is a lot of scope to widen the testing market. Finding pathological labs at near sight is crucial in terms of getting speedy results with less effort. Flooding pathological labs also increased the susceptibility of wrong results that’s turns people to find authentic laboratory with reliable results. 

Pathology laboratory data is scare in United States, people and organizations are looking for actual figure of pathological labs in United States across various states. Advent of Artificial Intelligence and advanced technologies accelerated the pace of speedy results and making easier for blood collection. Rising population, changing disease landscape, penetration of advanced technology among others are driving growth of pathological labs demand in United States.  

 Diagnostic and Medical Laboratories businesses in United States is expanding at a large scale and growing at a rate of 2.46% from 2022. Pathology services account for about 60-72% of the total diagnostic market. 

Trends: Trends such as advancements in medical technologies, proximity of healthcare facilities, prices among others are the key factors governing diagnosis industry in United States.

Report Analysis Covers Below Pointers:

• Introduction
• Market Size and Forecast Demand
• Current Landscape and Futuristic Scope
• # of Pathological Labs in United States
• Number of Footfall in a Day
• Price Analytics for Different Tests
• Number of Individual Labs vs Big Franchise Analysis
• Analysis on Sample Collection Center
• Competitive Landscape (Sales Analytics, Market Share, Key Players Operating in the Geography)
• Duration of Report
• Analysis on Challenges Faced at Sample Collection Centers
• Patients Segregation Analysis by Speciality 
• Way Forward

Reason to Buy Report:

• Understanding Pathological Landscape in United States
• Companies Dealing in Blood Analysis Equipment Needs to Target Appropriate Segment
• To understand United States Potential in Chronic Disease Segments
• Impact of Technology on Pathology Laboratory

Key Stakeholders:

• Hospitals and Healthcare Centers
• Pathological Laboratories
• Diagnostic Equipment Companies
• Pharmaceutical Companies
• Investors